TITLE

sexuality and SCI

AUTHOR(S)
Ducharme, Stanley
PUB. DATE
August 2009
SOURCE
PN;Aug2009, Vol. 63 Issue 8, p54
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article offers news briefs related to sex in the U.S. The Food and Drug Administration (FDA) has recently approved the use of female condom in the country. Various pharmaceutical companies in the country is still finding an effective treatment for women who have sexual dysfunction. Moreover, intrathecal baclofen was reported to be an ineffective drug in the erection of men with spinal-cord injury (SCI).
ACCESSION #
43202510

 

Related Articles

  • Update.  // Medical Marketing & Media;Nov2011, Vol. 46 Issue 11, p9 

    The article offers news briefs in the U.S. including the release of the innovation blueprint by the U.S. Food & Drug Administration (FDA), the resignation of David Kramer of Digitas and Razorfish Health, and the use of patient navigators in increasing minority involvement in clinical trials.

  • PROFESSIONAL MARKETING: Update.  // Medical Marketing & Media;Oct2012, Vol. 47 Issue 10, p19 

    The article offers news briefs related to the U.S. pharmaceutical industry as of October 2012 on topics including the first Content Marketing World Summit, layoff plans of Sanofi SA, and obesity drugs approvals by the Food & Drug Administration (FDA).

  • FDA Clears J&J, Medivir Hepatitis C Pill for Market.  // Chain Drug Review;12/16/2013, Vol. 35 Issue 20, p86 

    The article offers news briefs on the pharmaceutical industry in the U.S. including approval of the drug simeprevir by the U.S. Food and Drug Administration, plans of Horizon Pharma Inc. to buy the rights to sell the drug Vimovo in the country, and approval of Noxafil tablets by FDA.

  • Celgene Inks Agreement To Cooperate With Forma.  // Chain Drug Review;4/28/2014, Vol. 36 Issue 7, p215 

    The article offers the U.S. pharmaceutical industry news briefs as of April 28, 2014 including an agreement between Celgene Corp. and Forma Therapeutics, the Food and Drug Administration's (FDA) approval to Novaitis AG, and FDA Commissioner Margaret Hamburg's call for regulatory flexibility.

  • FDA Approves Drug to Stop Migraines in Young People.  // Chain Drug Review;4/28/2014, Vol. 36 Issue 7, p226 

    The article offers the U.S. pharmaceutical industry news briefs as of April 28, 2014 including the U.S. Food and Drug Administration's (FDA) approval for Topamax drug to prevent migraine headaches in adolescents, FDA's approval Pradaxa drug and availability of Aptiom drug by prescription.

  • Nexium 24HR Is Cleared To Enter the 0-T-C Market.  // Chain Drug Review;4/28/2014, Vol. 36 Issue 7, p226 

    The article offers the U.S. pharmaceutical industry news briefs as of April 28, 2014 including the U.S. Food and Drug Administration's (FDA) approval for over-the-counter Nexium 24HR drug, presence of acetaminophen in painkillers above FDA recommended dose and new logo design of Herb Pharm.

  • NEWSLINE.  // MPR - Pharmacist's Edition;Winter2015/2016, Vol. 9 Issue 4, pA5 

    This section offers news briefs related to the pharmaceutical industry in the U.S. Topics discussed include an approval granted by the U.S. Food and Drug Administration (FDA) to Nucala for injection as add-on maintenance treatment in patients with severe asthma, and an FDA approval for Novartis'...

  • FDA Approves Treatment for Two Forms Of Cancer.  // Chain Drug Review;5/19/2014, Vol. 36 Issue 8, p69 

    The article offers news briefs related to U.S. drug industry as of May 2014 on topics including U.S. Food and Drug Administration's (FDA) approval for anticancer drug Cyramza (ramucirumab), marketing of the drug Bloxiverz by Eclat Pharmaceuticals, and FDA's approval for Zykadi for lung cancer.

  • Lilly's Taltz Approved For Plaque Psoriasis.  // Chain Drug Review;4/18/2016, Vol. 38 Issue 7, p248 

    The article offers news briefs related to the U.S. pharmaceutical industry including the approval by the Food and Drug Administration to Eli Lilly and Co.'s Taltz injection and Jazz Pharmaceuticals' Defitelio, and the final acquisition of Vantage Oncology LLC and Biologics Inc. by McKesson Corp.

  • Leading Indicators. Koroneos, George // Pharmaceutical Executive;Oct2007, Vol. 27 Issue 10, p21 

    The article offers news briefs related to the pharmaceutical industry in the U.S. The Food and Drug Administration has approved FluMist, inhaled influenza vaccine from MedImmune Inc. Johnson & Johnson announces the layoff of approximately 700 permanent and temporary employees. Merck & Co. Inc....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics